JPRN-UMIN000004543已完成未知
A Phase II Study of Carboplatin and Pemetrexed for elderly patients with Non-Small Cell (Non Squamous cell)Lung Cancer - A Phase II Study of Carboplatin and Pemetrexed for elderly patients with Non-Small Cell (Non Squamous cell)Lung Cancer
Toracic Medical Oncology,Cancer Institute Hospital of JFCR0 个研究点目标入组 42 人开始时间: 2010年11月11日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 42
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 70years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Subjects with interstitial pneumonia or pulmonary fibrosis. Uncontrolled Active infection. Subjects with symptomatic brain metastases. Concurrent use of steroid therapy. Uncontrolled pleural. Subjects with previous malignancies. Any other reason that,in the opinion of the investugator precludes the subject from participating in the study.
研究者
相似试验
已完成
2 期
A Phase 2 study of pemetrexed and carboplatin for platinum-pretreated patients with non small cell lung cancerplatinum pretreated patients with non small cell lung cancerJPRN-UMIN000005552Osaka Prefectural Medical Center for Respiratory and Allergic deseases30
已完成
2 期
Phase II study of carboplatin and pemetrexed plus bevacizumab after failure of first-line EGFR TKI therapy for non-small-cell lung cancer harboring EGFR mutation.on-squamous Non-small-cell Lung CancerJPRN-UMIN000004731Central Japan Lung Study Group27
已完成
不适用
A Phase 2 Study of Carboplatin, Pemetrexed, and Bevacizumab followed by Bevacizumab and Erlotinib maintenance for Non-squamous Non-Small Cell Lung Cancer not harboring EGFR mutations. (HOT1101)JPRN-UMIN000005872Hokkaido Lung Cancer Clinical Study Group51
已完成
2 期
Phase II study of Pemetrexed and Carboplatin plus Bevacizumab for advanced non-small cell lung cancernon-squamous non-small-cell lung cancerJPRN-UMIN000003680ippon Medical School Hospital26
已完成
2 期
Phase II study of Pemetrexed + Carboplatin as first line therapy for nonsquamous non-small cell lung cancer with interstitial pneumoniaJPRN-UMIN000011325Central Japan Lung Study Group (CJLSG)25